Posted: July 3, 2020

Letter of Intent due September 30, 2020; Application due October 30, 2020

This funding opportunity announcement aims to support research that employs innovative scalable technologies to identify, map, and profile cellular ensembles and/or cell-types that produce and/or respond to opioids or that are engaged during different stages of opioid use (acute, chronic, withdrawal, abstinence, relapse). Emphasis is on approaches that enable high-throughput single-cell resolution mapping, anatomical characterization and/or molecular profiling of cells identified as targets of, or as primary sources of opioids in the brain.

See full solicitation here

Office of Grants and Contracts


107 Ag Administration Building
University Park, PA 16802